Becton, Dickinson Shares Decline Following In-Line Fiscal 2027 Revenue Guidance
Becton, Dickinson (BDX) saw its shares decline in premarket trading despite reporting fourth-quarter fiscal 2026 financial results that exceeded analyst expectations. The downward pressure on the stock stems from the company's forward-looking guidance for fiscal 2027. The MedTech provider issued revenue growth projections for fiscal 2027 that align closely with existing consensus estimates. While the Q4 performance was strong, investors appear to be reacting to the lack of an upward surprise in the long-term outlook.
Tickers: $BDX
Topics: earnings report revenue guidance stock price movement
Read the full article at Seeking Alpha
Part of the story Under Armour Reports Q2 Fiscal 2027 Revenue Decline Amid Strategic Restructuring (7 articles)